Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: Tesco, ITV, Glaxo

Sun, 31st Aug 2014 17:42

Harris Associates, the US investment fund that has been one of Tesco's biggest and most loyal shareholders, has sold almost two thirds of its stake because it thinks the supermarket group has become too risky, the Sunday Telegraph reported. David Herro, Harris's chief executive, said there were too many "unknowns" surrounding Tesco and that he wanted to hear what Dave Lewis, the new chief executive, planned for the group.Tesco has given Dave Lewis, its new Chief Executive, a "blank sheet" to decide the company's future, the Sunday Times said. He is likely to cut prices in the UK, assess peripheral businesses such as Blink-box and Tesco Bank, and consider a listing or partial sale of the Asian business.Liberty Global is seeking the support of big ITV shareholders, suggesting that the US company is considering a bid for the UK broadcaster, the Sunday Telegraph said. Liberty, which owns 6.4% of ITV, is said to be seeking a stronger position in future talks with ITV's board by building relations with US fund managers that own shares of the UK company. Liberty is trying to gain support for a bid at a modest premium to ITV's share price, which is at its highest since the dotcom crash.Top shareholders of GlaxoSmithKline want the early departure of Chairman Sir Chris Gent, the Sunday Times said. Gent has said he will leave the drug company next year but with the company hit by a corruption scandal in China and the share price suffering, the investors want Gent to go this year. They are considering approaching Glaxo's Senior Independent Director, Sir Deryck Maughan, about the matter.An activist investor has increased its stake in NBNK Investments and wants the investment vehicle to sue Lloyds Banking Group over the sale process for its TSB business, the Sunday Telegraph said. Crystal Amber owns almost 28% of NBNK, which was set up to buy banking assets. NBNK tried to buy Lloyds's TSB business but was rejected in favour of the Co-operative Bank, whose bid fell apart. Crystal Amber wants NBNK to sue Lloyds to recover its costs from the sale process.RAC intends to include a retail offering when it launches its stock market flotation in the next few weeks, the Sunday Telegraph reported. The roadside recovery business is ready to announce a stock market offering valuing it at about £2bn, though its private equity owner Carlyle has also sounded out other buyout firms on whether they are interested in buying RAC.Hargreaves Lansdown is close to announcing it will apply for a full banking licence, the Mail on Sunday reported, citing Morgan Stanley analysts. The analysts estimate that the investment company oversees £3.8bn of client money but without a banking licence it has to place the funds with other banks. Hargreaves could announce the planned application, which would let it pay better rates of interest on clients' cash, with its annual results on September 3rd.Afren, the oil explorer, is considering chasing its suspended Chief Executive, Osman Shahenshah, and other top managers for tens of millions of dollars of alleged "unauthorised payments" discovered in an investigation into its Nigerian business, the Sunday Times said. The company suspended Shahenshah last month along with operations chief Shahid Ullah over payments they allegedly received from a third party. Crystal Amber, an activist investor, has built a stake in Aer Lingus and wants the Irish airline to limit payments to cut the deficit in its pension scheme, the Sunday Times said. With almost 3% of Aer Lingus shares, Crystal Amber is the biggest investor in the company behind Ryanair and Etihad, the Gulf airline. It said the €191m Aer Lingus recently paid into the retirement fund for Irish airline staff was "the absolute limit" for shareholders.The European Central Bank (ECB) is set to pave the way for a big stimulus programme to stop the Eurozone entering a deflationary spiral, the Sunday Times said. With Japan-style price falls close, economists think the ECB could use its 4 September monetary policy meeting to confirm the purchase of between €50bn and €5200bn of bank loans to boost lending and the economy.Crossrider, an advertising business backed by Israeli billionaire Teddy Sagi, is planning a London listing that will value it at about $250m, according to the Sunday Times. The company collects data to match on-line advertisers with internet surfers.
More News
Today 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
Today 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.